Home › Funding › Funding Priorities › NIDA Funding Strategy › NIDA Funding Strategy for Fiscal Year 2009
External link, please review our disclaimer.
NIDA Funding Strategy for Fiscal Year 2009
Funding
- Funding Opportunities
- Clinical Research
- Post-Award Concerns
- General Information
- Grant & Contract Application Process
- Funding Priorities
- NIDA Funding Strategy
- NIDA Funding Strategy for Fiscal Year 2012
- NIDA Funding Strategy for Fiscal Year 2011
- NIDA Funding Strategy for Fiscal Year 2010
- NIDA Funding Strategy for Fiscal Year 2009
- NIDA Funding Strategy for Fiscal Year 2008
- NIDA Funding Strategy for Fiscal Year 2007
- NIDA Funding Strategy for Fiscal Year 2006
- Technology Transfer
- NIDA Funding Strategy
- Research Training
Based on the enacted Omnibus appropriation, the National Institute on Drug Abuse (NIDA) has established the following funding policy.
New and Competing (Type 1 & 2)
New and competing grants will be funded at a 3% increase over FY 2008.
Non-competing Continuations (Type 5)
- All non-competing continuations (modular and non-modular) will be funded at 100% of committed levels.
- Information regarding the NIH NIH Fiscal Policy for Grant Awards - FY 2009 can be found at http://grants.nih.gov/grants/guide/notice-files/NOT-OD-09-066.html
New Investigators
- NIDA is committed to supporting first-time R01 investigators and Early Stage Investigators (by NIH definition). This means new investigator status will be considered in funding decisions and is one factor in funding grants beyond the normal payline. For the policy on New and Early Stage Investigators go to http://grants.nih.gov/grants/guide/notice-files/NOT-OD-09-013.html.
Ruth L. Kirschstein National Research Service Awards (NRSA)
NIH has established new increased stipend levels for fiscal year 2009 NRSA awards. For more information visit http://grants.nih.gov/grants/guide/notice-files/NOT-OD-09-075.html
Search for Funding
Featured Publication
Mentoring: A Guide for Drug Abuse Researchers
Discusses the importance of quality mentorship in drug abuse research and offers suggestions for creating a successful mentor and mentee relationship.